2,4-dibenzyloxybenzoic acid derivatives and their preparation methods and applications

A technology of dibenzyloxybenzoic acid and derivatives, applied in 2 fields, can solve the problems of low oral bioavailability of peptide antagonists, limit the application of cardiovascular diseases, etc., and achieve the effect of strong endothelin receptor antagonistic activity

Active Publication Date: 2015-11-18
SOUTHEAST UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Peptide ET antagonists with strong effects have been found to include BQ123, BQ160, FR2139317, etc., but the low oral bioavailability of peptide antagonists limits their application in cardiovascular diseases requiring long-term medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2,4-dibenzyloxybenzoic acid derivatives and their preparation methods and applications
  • 2,4-dibenzyloxybenzoic acid derivatives and their preparation methods and applications
  • 2,4-dibenzyloxybenzoic acid derivatives and their preparation methods and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 12

[0051] Embodiment 12, the preparation of 4-dihydroxybenzonitrile (1c)

[0052] (1) Preparation of 2,4-dihydroxybenzaldehyde oxime (1c1)

[0053] Dissolve 28g (0.4mol) of hydroxylamine hydrochloride in 20ml of water, drop into 20ml of aqueous solution of 23g (0.41mol) of KOH under cooling, add 50ml of absolute ethanol and 20ml of glacial acetic acid to prepare this solution for later use. Dissolve 50g (0.362mol) of 2,4-dihydroxybenzaldehyde in 150ml of absolute ethanol, add the above standby solution under cooling, after addition, reflux for 0.5hr, cool to room temperature, filter the resulting potassium chloride, and concentrate the filtrate To dryness, the residue was recrystallized from water to obtain 53.5 g of white needle crystals, yield 96%, mp 191-192°C (191°C in literature).

[0054] (2) Preparation of 2,4-diacetoxybenzonitrile (1c2)

[0055] React 3.4g (0.022mol) of compound 2,4-dihydroxybenzaldehyde oxime with 20ml of acetic anhydride under reflux for 8 hours, cool...

Embodiment 2

[0057] Saponify 60g (0.274mol) of the compound 2,4-diacetoxybenzonitrile in a 700ml aqueous solution containing 50g NaOH for 1.5hr at room temperature, then adjust the pH to 3 with 10% HCl, extract the aqueous solution with 5×100ml ether, Dry over anhydrous magnesium sulfate, distill off the solvent to obtain 34 g of white needle crystals, yield 92%, mp 179-181°C (179°C in literature). The preparation of embodiment 2 p-methoxybenzyl chloride (2c)

[0058] Dissolve 27g (0.2mol) anisaldehyde in 80ml methanol, add 20ml water, add 5g (0.1mol) KBH in batches 4 , After the addition, react at room temperature for 2hr, adjust the pH=3 with 10% HCl under cooling, and then use saturated NaHCO 3 Neutralize to pH=8, evaporate methanol under reduced pressure, a large amount of oil appears, extract with toluene, wash with water and saturated NaCl successively, dry over anhydrous magnesium sulfate, evaporate the solvent to obtain 30.7 g of colorless transparent liquid, yield 98 %.

[0059...

Embodiment 35

[0061] The preparation of embodiment 35-chloromethyl-2,1,3-benzoxadiazole (2f)

[0062] (1) Preparation of 4-chloro-3-nitrobenzaldehyde (2f1)

[0063] Add 70g (0.5mol) p-chlorobenzaldehyde in batches to 55ml of fuming nitric acid and 55ml of concentrated sulfuric acid at <10°C, then react at this temperature for 2hr, after the reaction is complete, pour the reaction solution into ice water, The precipitated oil was solidified, filtered, and recrystallized with 70% ethanol to obtain 90 g of white needle crystals, yield 97%, mp62-63°C.

[0064] (2) Preparation of 4-azido-3-nitrobenzaldehyde (2f2)

[0065] Dissolve 46.4g (0.25mol) of the compound 4-chloro-3-nitrobenzaldehyde in 300mlDMSO, and add 18g (0.276mol) of NaN 3 , control the temperature <30°C, then stir at room temperature for 1 hr, after the reaction is complete, pour the reaction solution into 100ml of ice water to precipitate a light yellow powdery solid, filter, wash with water until the filtrate is colorless, and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a 2,4-dibenzyloxybenzoic acid derivative shown by a formula (I) or pharmaceutically acceptable salts thereof, and also provides a preparation method of the 2,4-dibenzyloxybenzoic acid derivative or pharmaceutically acceptable salts thereof and an application thereof in preparing a medicine for treating cardiovascular and cerebrovascular diseases, tumors, diabetes mellitus, nephrosis, asthma or hyperthyroidism.

Description

technical field [0001] The invention belongs to the field of medicine and chemical industry, and particularly relates to 2,4-dibenzyloxybenzoic acid derivatives, as well as its preparation method and application. Background technique [0002] The mortality rate of cardiovascular and cerebrovascular diseases ranks first among all kinds of diseases, and the final cause of death is overwhelmingly myocardial hypertrophy, heart failure (heart failure), stroke or fatal arrhythmia. Especially in recent years, the fatality rate of severe heart failure has remained high, which has become a difficult problem in the international medical community. These diseases currently lack effective therapeutic drugs. [0003] Endothelin (endothclin, ET) is an active polypeptide containing 21 amino acids synthesized and secreted by vascular endothelial cells, cardiac muscle, smooth muscle, etc. Injury factors play an important role in the pathogenesis of many heart, brain, lung, kidney and vascu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C59/68C07C51/09C07D317/54C07D271/12C07D285/14C07C65/24C07C255/54C07C253/30C07C255/37A61K31/192A61K31/194A61K31/277A61K31/36A61K31/4245A61K31/433A61P9/00A61P35/00A61P3/10A61P13/12A61P11/06A61P5/16
CPCC07C59/90C07C65/24C07C255/37C07C255/57C07D271/08C07D285/10C07D317/54
Inventor 蔡进吉民
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products